• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Trimel Pharmaceuticals Corp

+ Add to Watchlist

3TP:GR

0.324 EUR 0.006 1.82%

As of 02:00:09 ET on 08/22/2014.

Snapshot for Trimel Pharmaceuticals Corp (3TP)

Open: 0.324 Day's Range: 0.324 - 0.324 Volume: 0
Previous Close: 0.330 52wk Range: 0.309 - 0.598 1-Yr Rtn: -

Stock Chart for 3TP

No chart data available.
  • 3TP:GR 0.324
  • 1D
  • 1M
  • 1Y
0.330
Interactive 3TP Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 3TP

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -0.1000
Est. PEG Ratio -
Market Cap (M EUR) 52.85
Shares Outstanding (M) 163.13
30 Day Average Volume 27
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/03/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 3TP

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for 3TP

Trimel Pharmaceuticals Corp. is a pharmaceutical development company. The Company's primary objective is to exploit Trimel's drug-delivery technology portfolio and to target unmet medical needs in underserved disease states. Trimel's term objectives include the development of products for the treatment of male hypogonadism, female sexual dysfunction, and Parkinson's disease.

Tom RossiPresident/CEOKenneth G HowlingChief Financial Officer
Nathan John BrysonVP:Chief Scientific Officer
More Company Profile & Key Executives for 3TP

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil